Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: Effect of antidepressants

Neuroscience

Volumn 102, Issue 1, 2001, Pages 151-158

  Cyr, M ^a   Morissette, M ^a   Barden, N ^b   Beaulieu, S ^c   Rochford, J ^c   Di Paolo, T ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Amitriptyline; Dopamine; Fluoxetine; In situ hybridization; Transgenic mice

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLALLYL)PIPERAZINE; 1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMITRIPTYLINE; AMPHETAMINE; ANTIDEPRESSANT AGENT; COMPLEMENTARY RNA; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE TRANSPORTER; FLUOXETINE; GLUCOCORTICOID RECEPTOR; HOMOVANILLIC ACID; RACLOPRIDE; SPIPERONE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC TRANSMISSION; DRUG RECEPTOR BINDING; FEMALE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN SITU HYBRIDIZATION; LOCOMOTION; MALE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; BINDING SITES; CARRIER PROTEINS; DEPRESSION; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FLUOXETINE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; NEOSTRIATUM; NERVE TISSUE PROTEINS; NEURONS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GLUCOCORTICOID; STRESS; SUBSTANTIA NIGRA;

EID: 0035793021     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00444-9     Document Type: Article

References (77)

1. Effect of antidepressant drugs on dopamine D1 and D2 receptor expression and dopamine release in the nucleus accumbens of the rat
2. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
3. Modulation of glucocorticoid receptor gene expression by antidepressant drugs
4. Regulation of corticosteroid receptor gene expression in depression and antidepressant action
5. Behavioural and endocrine impact of impaired type II glucocorticoid receptor function in a transgenic mouse model
6. Fluoxetine reduces inflammatory edema in the rat: Involvement of the pituitary-adrenal axis
7. Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors
8. Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls
9. Modulation of the locomotor response to amphetamine by corticosterone
10. Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat
11. Behavioural sensitization of mesolimbic dopamine D2 receptors in chronic fluoxetine-treated rats
12. The corticosterone synthesis inhibitor metyrapone decreases dopamine D1 receptors in the rat brain
13. A physiological dose of progesterone affects rat striatum biogenic amine metabolism
14. Prenatal corticosterone increases spontaneous and d-amphetamine induced locomotor activity and brain dopamine metabolism in prepubertal male and female rats
15. Noradrenergic and serotonergic abnormalities in depression: Stress-induced dysfuction?
16. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone
17. Effects of repeated fluoxetine on anxiety-related behaviours, central serotonergic systems, and the corticotropic axis axis in SHR and WKY rats
18. Repeated administration of antidepressant drugs affects the levels of mRNA coding for D1 and D2 dopamine receptors in the rat brain
19. Changes in dopamine receptor mRNA expression following chronic mild stress and chronic antidepressant treatment
20. The effect of prolonged treatment with imipramine on the biosynthesis and functional characteristics of D2 dopamine receptors in the rat caudate putamen
21. Dopamine and depression - Striatal dopamine D2 receptor SPECT before and after antidepressant therapy
22. Regional effect of estradiol on rat caudate-putamen dopamine receptors: Lateral-medial differences
23. Endocrine regulation of neurotransmitter transporters
24. Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors
25. Presynaptic effects of glucocorticoids on dopaminergic and cholinergic synaptosomes. Implications for rapid endocrine-neural interactions in stress
26. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility
27. Effect of desipramine during infancy and preweaning on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat
28. Repeated dexamethasone suppression test during depressive illness. Normalisation of test result compared with clinical improvement
29. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
30. Effect of antidepressants on striatal and accumbens extracellular dopamine levels
31. + channels
32. Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems
33. 123I]IBZM SPECT
34. Regulation of striatal dopamine receptors by corticosterone: An in vivo and in vitro study
35. In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression
36. Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats
37. On the in-vivo modulation of neostriatal dopamine release by fluoxetine and 5-hydroxy-l-tryptophan in conscious rats
38. Glucocorticoid effects on mesotelencephalic dopamine neurotransmission
39. Protein measurement with folin reagent
40. Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, [3H]N-0437, to dopamine D2 receptors in the rat brain
41. Repeated treatment with antidepressant drugs increases the behavioural response to apomorphine
42. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine
43. Influence of ACTH on tyrosine hydroxylase activity in the locus coeruleus of mouse brain
44. Comparison between uptake2 and rOCT1: Effects of catecholamines, metanephrines and corticosterone
45. Effects of amitriptyline and nortriptyline on cerebral activity of the CDF-1 mouse strain
46. Biochemical effects of corticosteroids on neural tissues
47. Effect of chronic estradiol and progesterone treatments of ovariectomized rats on brain dopamine uptake sites
48. Effect of chronic estradiol treatment on brain dopamine receptor reappearance after irreversible blockade: An autoradiographic study
49. The psychoneuroendocrinology of depression: Hypothalamic-pituitary-adrenal axis dysregulation
50. Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area
51. Additive effects of chronic treatment with antidepressant drugs and intermittent treatment with a dopamine agonist
52. Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures
53. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene
54. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression
55. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission
56. Pathophysiological basis of vulnerability to drug abuse: Role of an interaction between stress, glucocorticoids, and dopaminergic neurons
57. Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system
58. Hypothalamic-pituitary-adrenocortical axis changes in the rat after long-term treatment with the reversible monoamine oxidase-A inhibitor moclobemide
59. Brain dopamine transporter: Gender differences and effect of chronic haloperidol
60. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding - An autoradiographic analysis
61. Glucocorticoid and mineralocorticoid receptors differentially modulate cultured dopaminergic neurons of rat ventral mesencephalon
62. Release of endogenous dopamine in cultured mesencephalic neurons: Influence of dopaminergic agonists and glucocorticoid antagonists
63. Test-specific effects of amytryptyline administration on behavioural deficits in transgenic mice with impared glucocorticoid receptor function
64. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding
65. Neuroendocrine-related effects of long-term, "binge" cocaine administration: Diminished individual differences in stress-induced corticosterone response
66. A corticosteroid/dopamine hypothesis for psychotic depression and related states
67. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression
68. Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: Influence of long-term treatment with the antidepressant moclobemide
69. Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization
70. Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor
71. Enhanced conditioned approach responses in transgenic mice with impaired glucocorticoid receptor function
72. Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells
73. The antisense strategy applied to the study of dopamine D3 receptor functions in rat forebrain
74. Differential responsiveness of central noradrenergic and dopaminergic neuron tyrosine hydroxylase to hypophysectomy, ACTH and glucocorticoid administration
75. Prospective controlled studies of the behavioural and biological effects of exogenous corticosteroids
76. Long-term fluoxetine produces behavioural anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats